Designing Clinical Studies for Reimbursement and Market Access

This white paper discusses the critical role of clinical study design in ensuring regulatory compliance and securing reimbursement for medical devices. It outlines how optimal trial designs can generate valid data necessary for market access in the United States and European Union. The paper presents various case studies that illustrate successful clinical trial outcomes achieved through thoughtful design, while also addressing the pitfalls of inadequate study planning. It emphasizes the importance of internal and external validity in trials, which are essential for demonstrating the clinical and economic value of medical technologies. Additionally, the document details RQM+'s strategic approach to clinical trial design, focusing on early engagement, tailored execution, and comprehensive post-market planning. The paper concludes with recommendations for manufacturers on how to align clinical trials with market access strategies, aiming to maximize value and accessibility for innovative medical devices.